Research ArticleCardiovascular
Triiodothyronine reduces vascular dysfunction associated with hypertension by attenuating PKG/VASP signaling.
Maria Alicia Carrillo-Sepulveda, Anjali Panackal, Renjith Maracheril, Nicole Maddie, Mitul N Patel, Kaie Ojamaa, Olga V Savinova and A. Martin Gerdes
Journal of Pharmacology and Experimental Therapeutics July 12, 2019, jpet.119.260471; DOI: https://doi.org/10.1124/jpet.119.260471
Maria Alicia Carrillo-Sepulveda
NYIT-COM
Anjali Panackal
NYIT-COM
Renjith Maracheril
NYIT-COM
Nicole Maddie
NYIT-COM
Mitul N Patel
NYIT-COM
Kaie Ojamaa
NYIT-COM
Olga V Savinova
NYIT-COM
A. Martin Gerdes
NYIT-COM
Article Figures & Data
Additional Files
Data Supplement
- Supplemental Data -
Supplemental methods, 2 figures.
- Supplemental Data -
In this issue
Research ArticleCardiovascular
Triiodothyronine reduces vascular dysfunction associated with hypertension by attenuating PKG/VASP signaling.
Maria Alicia Carrillo-Sepulveda, Anjali Panackal, Renjith Maracheril, Nicole Maddie, Mitul N Patel, Kaie Ojamaa, Olga V Savinova and A. Martin Gerdes
Journal of Pharmacology and Experimental Therapeutics July 12, 2019, jpet.119.260471; DOI: https://doi.org/10.1124/jpet.119.260471
Research ArticleCardiovascular
Triiodothyronine reduces vascular dysfunction associated with hypertension by attenuating PKG/VASP signaling.
Maria Alicia Carrillo-Sepulveda, Anjali Panackal, Renjith Maracheril, Nicole Maddie, Mitul N Patel, Kaie Ojamaa, Olga V Savinova and A. Martin Gerdes
Journal of Pharmacology and Experimental Therapeutics July 12, 2019, jpet.119.260471; DOI: https://doi.org/10.1124/jpet.119.260471
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement